Form D · Biotechnology

XENTER, INC.

Draper, UT · CIK 0001838073

Offering snapshot reported Jan 6, 2023 · SEC filing

Reported sold: $19.6M
Investors reported: 79
Minimum accepted: $100K
First sale: Jun 30, 2021

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$1,000,000 → $19,595,500

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jan 6, 2023	Amendment	$19,595,500	$18,595,500vs Jul 14, 2021	79	SEC filing
Jan 6, 2023	Initial	$1,131,800	No comparison	12	SEC filing
Jul 14, 2021	Initial	$1,000,000	No comparison	Not reported	SEC filing
Jan 8, 2021	Initial	$2,803,712	No comparison	22	SEC filing

Offering details

Securities: Debt
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-406110

Source: Form D, filed Jan 6, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Baxter	Director, Executive
David Bearss	Director, Executive
Elazer Edelman	Director
Robert Langer	Director
Richard Linder	Director, Executive
Eric Pearson	Executive
David Sampson	Executive
Mark Stautberg	Director
James Tobin	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

344 West 13800 South, Ste. 400
Draper, UT, 84020